Pure Global AI
NCT06328894Not yet recruiting

Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients

A Randomized Controlled Trial to Explore the Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients
Copka SonpashanClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Ischemic Stroke
Drug/Device/Intervention
Nasogastric Tube Feeding
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Copka Sonpashan
Funder
Chao Phya Abhaibhubejhr Hospital
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Dec 01, 2024
Enrollment
80 participants
Primary outcome

Generalized Anxiety Disorder 7

Summary

The goal of this clinical trial is to compare the differences on Psychological Condition and
 Experience in ischemic stroke patients using Intermittent Oro-esophageal Tube and Nasogastric
 Tube. Patients will be randomly divided into an observation group and a control group, all
 receiving routine rehabilitation treatment. On this basis, the observation group will use
 Intermittent Oro esophageal Tube for enteral nutrition support, while the control group will
 use Nasogastric Tube. Researchers will compare Psychological Condition and Experience of two
 groups.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedOther cerebral infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06328894
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06328894 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Ischemic Stroke. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.